Antares Therapeutics spun off of Scorpion Therapeutics, a clinical-stage biotech that Eli Lilly acquired earlier this year. Like Scorpion, Antares is developing small molecules that go after undruggable targets in cancer. The post Cancer Drug Startup Antares Unveils $177M to Pick Up Where Scorpion Therapeutics Left Off appeared first on MedCity News.
Open Enrollment for 2025 Marketplace coverage starts November 1. Open Enrollment is right around the corner. Make sure you’re ready. Image Did you: Gather basic information (PDF, 163 KB)? You can fill out your application faster if you’re ready with information like birthdates and Social Security Numbers (SSNs).Check to see if you might save on…
Penobscot County, Maine, is grappling with the largest HIV outbreak in the state’s history. Home to Bangor, a city of roughly 32,000, the county has identified 28 new cases over nearly two years. That’s seven times the typical number for that length of time. Nearly all cases are among people who use drugs and are…
Amidst the distress caused by a cancer diagnosis, patients are left to sort through vast amounts of information, treatment options, and concerns around efficacy and side effects, while juggling other life activities. The post What We’re Still Getting Wrong in Cancer Care — Glaring Gaps in the Face of Astonishing Advancements appeared first on MedCity…
By DAVID INTROCASO After having worked in DC for sixteen years, in 2013 I created The Healthcare Policy Podcast. The title was in part intended to be sarcastic because healthcare policymaking in DC is very narrowly drawn. Consequently, healthcare delivery is excessively commodified, reductionistic and financialized or in sum anachronistic and ironically lacking purchase. If the…
This factsheet discusses breast cancer screening and prevention services, and reviews the scope of private and public insurance coverage, as well as access to those services for women in the US.
Payers will often look to disease analogs when making pricing and coverage decisions. These disease analogs can inform the level of rebates, need for prior authorization/utilization management, and the drug’s cost sharing tier. Traditionally, however, disease analogs are selected on an ad hoc basis. In a recent JMCP paper titled “A structured approach for identifying…
“Donald Trump said he was going to allow Medicare to negotiate drug prices. He never did. We did.” Vice President Kamala Harris at the ABC News presidential debate, Sept. 10 Since Vice President Kamala Harris entered the presidential race, she and former President Donald Trump have sparred over their approaches to lowering prescription drug costs….
As speculation about whether Medicaid cuts will be part of the solution to our national debt problem continues, no one can predict how much the Medicaid rollback will be, or its impact on the one in five Americans who rely on it. The post When Medicaid Cost Cutting Is Simply Cost Shifting appeared first on…
To improve outcomes further, healthcare providers will need to take bold action to diagnose and manage this kidney disease before it becomes chronic or fatal. The post Innovations Shaping the Future of Kidney Care appeared first on MedCity News.